Eye specialists are unsure when anti-VEGF treatment should start to achieve the best long-term outcome An estimated 9.6 million people in the U.S. had diabetic-related eye disease – roughly 26% of diabetics. Of study participants who had no signs of dDR at the start of the study, 18% developed some retinopathy at follow-up. AI may help increase health equity in diabetic eye disease (DED) testing by giving patients at risk access to screening Women are more likely to develop AMD because they are more likely to reach the age where the disease is most common. Many rural areas have a significant healthcare gap, severely affecting disorders like wet age-related macular degeneration. Individuals may forgo necessary preventive care and treatments for DME due to cost, potentially leading to worse outcomes. Hispanic and African American populations demonstrating higher rates of DME than their Caucasian counterparts. Social, economic, and environmental barriers can play a role in one's risk of diabetes. Dr. Subramanian discusses the impact of race on short-term treatment response to bevacizumab (Avastin).